Symptoms, health behavior and understanding of menopause therapy in women with premature menopause

References

• Research on the menopause in the 1990s. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 1996;866:1–107
   PubMed Web of Science ®Google Scholar
• Vujovic S, Brincat M, Erel T, et al. EMAS position statement: Managing women with premature ovarian failure. Maturitas 2010;67:91–3
   PubMed Web of Science ®Google Scholar
• Deeks AA, Gibson-Helm M, Teede H, Vincent A. Premature menopause: a comprehensive understanding of psychosocial aspects. Climacteric 2011;14:565–72
   PubMed Web of Science ®Google Scholar
• Hickey M, Saunders C, Partridge A, Santoro N, Joffe H, Stearns V. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 2008;19:1669–80
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16:203–4
   PubMed Web of Science ®Google Scholar
• Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: Long-term health consequences. Maturitas 2010;65:161–6
   PubMed Web of Science ®Google Scholar
• Main P, Robinson M. Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women’s Health Initiative. Pharmacoepidemiol Drug Safety 2008;17:861–8
   PubMed Web of Science ®Google Scholar
• Sturmberg JP, Pond DC. Impacts on clinical decision making – changing hormone therapy management after the WHI. Aust Family Physician 2009;38:249–51, 53–5
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J. Changes in women’s attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 2005;52:11–17
   PubMed Web of Science ®Google Scholar
• Deeks A, Zoungas S, Teede H. Risk perception in women: A focus on menopause. Menopause 2008;15:304–9
   PubMed Web of Science ®Google Scholar
• Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25–31
   PubMed Web of Science ®Google Scholar
• Travers C, O’Neill SM, King R, Battistutta D, Khoo SK. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status. Climacteric 2005;8:56–62
   PubMed Web of Science ®Google Scholar
• Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson H. Complementary and alternative therapies for the management of menopause-related symptoms. a systematic evidence review. Arch Intern Med 2006;166:1453–65
   PubMed Web of Science ®Google Scholar
• Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 2005;12:460–7
   PubMed Web of Science ®Google Scholar
• Liao KL, Wood N, Conway GS. Premature menopause and psychological well-being. J Psychosomat Obstet Gynecol 2000; 21:167–74
   PubMed Web of Science ®Google Scholar
• Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Instit 2012;104:386–405
   PubMed Web of Science ®Google Scholar
• Sayakhot P, Vincent A, Deeks A, Teede H. Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer. Menopause 2011;18:786–93
   PubMed Web of Science ®Google Scholar
• Singer D, Mann E, Hunter MS, Pitkin J, Panay N. The silent grief: psychosocial aspects of premature ovarian failure. Climacteric 2011;14:428–37
   PubMed Web of Science ®Google Scholar
• Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas 2011;68:224–32
   PubMed Web of Science ®Google Scholar
• Otte JL, Carpenter JS, Russell KM, Bigatti S, Champion VL. Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manage 2010;39:535–47
   PubMed Web of Science ®Google Scholar
• Vincent A, Farrell E. Premature menopause. In Dvornyk V, ed. Current Topics in Menopause. Bentham Science Publishers, 2013:414–41
   Google Scholar
• Rocca WA, Grossardt BR, Geda YE, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 2008;15:1050–9
   PubMed Web of Science ®Google Scholar
• Vincent A, Ranasinha S, Sayakhot P, Mansfield D, Teede H. Sleep difficulty mediates effects of vasomotor symptoms on mood in younger breast cancer survivors. Climacteric 2014 May 25. Epub ahead of print
   Web of Science ®Google Scholar
• Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95(7 Suppl 1):s1–66
   PubMedGoogle Scholar
• MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd, 2004
   Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Ebeling PR, Daly RM, Kerr DA, Kimlin MG. An evidence-informed strategy to prevent osteoporosis in Australia. Med J Aust 2013;198:90–1
   PubMed Web of Science ®Google Scholar
• Pasco JA, Henry MJ, Nicholson GC, Sanders KM, Kotowicz MA. Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med J Aust 2001;175:401–5
   PubMed Web of Science ®Google Scholar
• MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust 2006;184:27–31
   PubMed Web of Science ®Google Scholar
• van der Sluijs CP, Bensoussan A, Liyanage L, Shah S. Women’s health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause 2007;14:397–403
   PubMed Web of Science ®Google Scholar
• Greenlee H, Kwan ML, Ergas IJ, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat 2009;117:653–65
   PubMed Web of Science ®Google Scholar
• Davis SR, Lijovic M, Fradkin P, et al. Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer. Menopause 2010;17: 1004–9
   PubMed Web of Science ®Google Scholar
• Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson H. Complementary and alternative therapies for the management of menopause-related symptoms. a systematic evidence review. Arch Intern Med 2006;166:1453–65
   PubMed Web of Science ®Google Scholar
• Maclennan AH. Evidence-based review of therapies at the menopause. Int J evidence-based Healthcare 2009;7:112–23
   PubMedGoogle Scholar
• Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145: 869–79
   PubMed Web of Science ®Google Scholar
• Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057–71
   PubMed Web of Science ®Google Scholar
• Panjari M, Davis SR, Fradkin P, Bell RJ. Breast cancer survivors’ beliefs about the causes of breast cancer. Psychooncology 2012; 21:724–9
   PubMed Web of Science ®Google Scholar
• Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005; 162:1089–97
   PubMed Web of Science ®Google Scholar
• Tao M, Teng Y, Shao H, Wu P, Mills EJ. Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One 2011;6:e24661
   PubMed Web of Science ®Google Scholar
• Uygur D, Sengul O, Bayar D, Erdinc S, Batioglu S, Mollamahmutoglu L. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet 2005;273:17–19
   PubMedGoogle Scholar
• Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009;94:2277–83
   PubMed Web of Science ®Google Scholar
• Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause 2007;14:567–71
   PubMed Web of Science ®Google Scholar
• Hadjidakis DJ, Kokkinakis EP, Sfakianakis ME, Raptis SA. Bone density patterns after normal and premature menopause. Maturitas 2003;44:279–86
   PubMed Web of Science ®Google Scholar
• Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist 2006;11:1121–31
   PubMed Web of Science ®Google Scholar
• Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15–2
   PubMed Web of Science ®Google Scholar
• Wellons M. Cardiovascular disease and primary ovarian insufficiency. Semin Reprod Med 2011;29:328–41
   PubMed Web of Science ®Google Scholar
• Gulhan I, Bozkaya G, Uyar I, Oztekin D, Pamuk BO, Dogan E. Serum lipid levels in women with premature ovarian failure. Menopause 2012;19:1231–4
   PubMed Web of Science ®Google Scholar
• Akahoshi M, Soda M, Nakashima E, Shimaoka K, Seto S, Yano K. Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index. Circulation 1996;94:61–6
   PubMed Web of Science ®Google Scholar